Researcher
Marie Truyens
- Keywords (Ghent University):Inflammatory bowel disease
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Ghent University):Gastro-enterology
- See also: Marie Truyens (Flanders Institute for Biotechnology)
Affiliations
- Vandenbroucke Lab (Research group)
Member
From1 Oct 2019 → 31 Dec 2022 - Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → 24 Sep 2023 - Knowledge Management Centre Ghent (Administrative office)
Member
From15 Dec 2014 → 31 Dec 2014
Projects
1 - 1 of 1
- Holistic and temporal analysis of gut-brain communication during chronic gut inflammationFrom15 Nov 2019 → 30 Sep 2022Funding: BOF - doctoral mandates
Publications
1 - 10 of 32
- Idiopathic thrombocytopaenic purpura associated with inflammatory bowel disease : a multicentre ECCO CONFER case series(2023)
Authors: Hussein Mahajna, Bram Verstockt, Daniel Bergemalm, Fabiana Castiglione, Fransisco Rodríguez-Moranta, Edoardo Savarino, Frank Hoentjen, Talat Bessissow, Jagoda Pokryszka, Anneline Cremer, et al.
Pages: 722 - 727 - Editorial : LAG‐3‐depleting monoclonal antibody : a potential treatment for patients with ulcerative colitis?(2023)
Authors: Triana Lobatón Ortega, Marie Truyens
Pages: 359 - 360 - Comparison of short- and long-term effectiveness between anti-TNF and ustekinumab after vedolizumab failure as first-line therapy in Crohn’s disease : a multi-center retrospective cohort study(2023)
Authors: Ahmad Albshesh, Lian Bannon, Tali Sharar Fischler, Marie Truyens, Stephan R. Vavricka, Katja Tepes, Daniela Pugliese, Edoardo V. Savarino, Eran Zittan, David Drobne, et al.
- SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders : a prospective, real-life Belgian cohort study - the BELCOMID study(2023)
Authors: Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Hilde Lapeere, Tom Hillary, An Van Laethem, Kurt de Vlam, Patrick Verschueren, et al.
- Significant differences in IBD care and education across Europe : results of the pan-European VIPER survey(2023)
Authors: Jan Kral, Radislav Nakov, Vera Lanska, Brigida Barberio, Nicolas Benech, Andreas Blesl, Eduard Brunet, Tiago Capela, Lauranne Derikx, Gabriele Dragoni, et al.
Pages: 387 - 395 - Autoimmune pancreatitis in patients with inflammatory bowel disease : a real-world multicentre collaborative ECCO CONFER study(2023)
Authors: Piotr Eder, Bram Verstock, Emma Culver, Gabriele Dragoni, Lea Isabell Kredel, Joanna Wypych, Ana Garcia Garcia de Paredes, Magdalena Kaniewska, Haim Leibovitzh, Triana Lobatón Ortega, et al.
Pages: 1791 - 1799 - A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)(2022)Volume: 16
Authors: Marie Truyens, Triana Lobatón Ortega, Anneleen Peeters, Marc Ferrante, Séverine Vermeire, Peter Bossuyt, Lieven Pouillon, Pieter Dewint, Anneline Cremer, Harald Peeters, et al.
Pages: i029 - i032 - The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study(2022)
Authors: Cara De Galan, Marie Truyens, Harald Peeters, Francisco Mesonero Gismero, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocio Ferreiro- Iglesias, Tom Holvoet, et al.
Pages: 1676 - 1686 - Infliximab re-challenge : could it be an option in refractory IBD patients?(2022)Volume: 16
Authors: Marie Truyens, Eva Pijoan Comas, ELIEN GLORIEUS, Jeroen Geldof, Triana Lobatón Ortega
Pages: i315 - i316 - Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel fisease : an ECCO CONFER multicentre case series(2022)
Authors: Stefano Festa, Giulia Zerboni, Lauranne A A P Derikx, Davide Giuseppe Ribaldone, Gabriele Dragoni, Christianne Buskens, Els Nieveen van Dijkum, Daniela Pugliese, Francesco Panzuto, Iwona Krela-Kazmierczak, et al.
Pages: 940 - 945